Global health programs targeting HIV/AIDS and tuberculosis got a surprise boost on Tuesday when the House Appropriations Committee took up the foreign affairs spending bill. Rep. Nita Lowey, D-N.Y., successfully offered an amendment adding $50 million to global TB programs, a welcome move particularly given growing threat of drug-resistant TB. This boost followed a letter […]
Update: Click play below to listen to the interview with Center for Global Health Policy head Christine Lubinski. $63 billion sounds like a lot of money. That’s the price tag on President Barack Obama’s global health initiative, unveiled with some fanfare last month and the target of contentious debate ever since. But how far will […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]